Treatment of UC With Novel Therapeutics | MicrobiomeTrials← Back to trialsNCT06420375
Treatment of UC With Novel Therapeutics
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-05-27Est. Completion: 2026-12-01
Enrollment target: 20 participants Locations- Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States
Other microbiome trials you might be interested in
Ulcerative Colitis
The purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-a…
New York, United StatesEst. completion Jun 23, 2027
Ulcerative ColitisCrohn Disease
Probiotics are live microorganisms that provide health benefits when consumed in sufficient amounts. Traditional probiot…
Roma, ItalyEst. completion Sep 14, 2026
Recruiting
Ulcerative Colitis (Disorder)Guselkumab
In a real-world setting, this study systematically evaluates the clinical efficacy and safety of guselkumab (GUS) in the…
Wenzhou, ChinaEst. completion Dec 31, 2028